X-XSS-Protection: 1; mode=block X-Content-Type-Options: nosniff Strict-Transport-Security: max-age=63072000; includeSubDomains; preload

Results published by Investigator on first-in-human biodistribution and first PET imaging results of [Ga-68]EMP-100 in metastatic renal cell carcinoma

<< Back to the news list

Results published by Investigator on first-in-human biodistribution and first PET imaging results of [Ga-68]EMP-100 in metastatic renal cell carcinoma

6 Dec 2021 | [Ga-68]EMP-100, Collaborations

This first in‑human biodistribution and imaging study for 68Ga‑EMP‑100 in metastatic renal cell carcinoma independently carried out by LMU Munich, Germany, evaluated uptake characteristics in metastases and primary RCC.

Conclusion: Visualization of c-MET expression with 68Ga-EMP-100 PET imaging allows for clinicopathological staging in mRCC and has potential as a predictive biomarker of targeted therapies.

https://doi.org/10.1007/s00259-021-05596-6